SIRT1 and Alzheimer disease: Interestingly, aspirin, a common anti-inflammatory drug, was observed to boost SIRT1 levels and counteract microglial senescence-Aβ induced in vitro [58] Although aspirin reduced amyloid plaque in an AD mouse model, it was not demonstrated to reduce Alzheimer’s risk in clinical trials [58].